Chronic obstructive pulmonary disease and bronchiectasis

被引:45
作者
Novosad, Shannon A. [1 ]
Barker, Alan F. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97239 USA
关键词
bronchiectasis; COPD; phenotypes; prognosis; LUNG-FUNCTION DECLINE; NECROSIS-FACTOR-ALPHA; PSEUDOMONAS-AERUGINOSA; ALPHA-1-ANTITRYPSIN DEFICIENCY; PROMOTER POLYMORPHISM; ACUTE EXACERBATIONS; AIRWAY DIMENSIONS; COPD; EMPHYSEMA; PREVENTION;
D O I
10.1097/MCP.0b013e32835d8312
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review Chronic obstructive pulmonary disease (COPD) and bronchiectasis are two different but related diseases that occur separately, but can coexist. In this review, we will examine the recent research regarding patients with COPD who have coexisting bronchiectasis. Recent findings Recent research has focused on defining distinct COPD phenotypes with the ultimate goal of changing the outcomes using tailored therapies. A frequent exacerbator phenotype has been identified. COPD patients with Pseudomonas aeruginosa are a phenotype with worse outcomes. Patients with coexisting COPD and bronchiectasis may represent a unique phenotype. Summary Patients with coexisting COPD and bronchiectasis could represent a unique phenotype with more severe disease, worse outcomes, more isolation of potentially pathogenic microorganisms, and more frequent exacerbations, with the potential for targeted therapies.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 59 条
  • [41] Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care
    O'Brien, C
    Guest, PJ
    Hill, SL
    Stockley, RA
    [J]. THORAX, 2000, 55 (08) : 635 - 642
  • [42] Parameswaran GI, 2012, FUTURE MICROBIOL, V7, P1129, DOI [10.2217/FMB.12.88, 10.2217/fmb.12.88]
  • [43] Prevalence and impact of bronchiectasis in α1-antitrypsin deficiency
    Parr, David G.
    Guest, Peter G.
    Reynolds, John H.
    Dowson, Lee J.
    Stockley, Robert A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (12) : 1215 - 1221
  • [44] Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease
    Patel, IS
    Vlahos, I
    Wilkinson, TMA
    Lloyd-Owen, SJ
    Donaldson, GC
    Wilks, M
    Reznek, RH
    Wedzicha, JA
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (04) : 400 - 407
  • [45] Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations
    Patel, IS
    Seemungal, TAR
    Wilks, M
    Lloyd-Owen, SJ
    Donaldson, GC
    Wedzicha, JA
    [J]. THORAX, 2002, 57 (09) : 759 - 764
  • [46] Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary
    Rabe, Klaus F.
    Hurd, Suzanne
    Anzueto, Antonio
    Barnes, Peter J.
    Buist, Sonia A.
    Calverley, Peter
    Fukuchi, Yoshinosuke
    Jenkins, Christine
    Rodriguez-Roisin, Roberto
    van Weel, Chris
    Zielinski, Jan
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (06) : 532 - 555
  • [47] Richman-Eisenstat JB, 1993, AM J PHYSL 1, V264, pL413
  • [48] Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease
    Rosell, A
    Monsó, E
    Soler, N
    Torres, F
    Angrill, J
    Riise, G
    Zalacaín, R
    Morera, J
    Torres, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (08) : 891 - 897
  • [49] Association of tumor necrosis factor-α gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD
    Sakao, S
    Tatsumi, K
    Igari, H
    Watanabe, R
    Shino, Y
    Shirasawa, H
    Kuriyama, T
    [J]. CHEST, 2002, 122 (02) : 416 - 420
  • [50] BRONCHIECTASIS IN PATIENTS WITH ALPHA-1-ANTITRYPSIN DEFICIENCY - A RARE OCCURRENCE
    SHIN, MS
    HO, KJ
    [J]. CHEST, 1993, 104 (05) : 1384 - 1386